Search

Your search keyword '"Bardia Nourbakhsh"' showing total 2 results
Start Over Author "Bardia Nourbakhsh" Journal journal of neurology
2 results on '"Bardia Nourbakhsh"'

1. COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis

Author

Paola Basilico, Lucia Abate, Andrea Salmaggi, Bardia Nourbakhsh, Vittorio Mantero, Roberto Balgera, and Christian Cordano

Subjects
2019-20 coronavirus outbreak, medicine.medical_specialty, Neurology, Multiple Sclerosis, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Dimethyl Fumarate, Clinical Neurology, Letter to the Editors, chemistry.chemical_compound, Multiple Sclerosis, Relapsing-Remitting, medicine, Humans, Neuroradiology, Dimethyl fumarate, business.industry, SARS-CoV-2, Multiple sclerosis, COVID-19, medicine.disease, Virology, chemistry, Neurology (clinical), business, Immunosuppressive Agents
Published
2020

2. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring

Author

M. Y. Ng, Riley Bove, Jeffrey M. Gelfand, Ari J. Green, Jennifer Graves, Matthew A. Tremblay, Antoine Lizee, Carolyn Bevan, Pierre-Antoine Gourraud, Elizabeth Crabtree-Hartman, Diane D. Allen, Bardia Nourbakhsh, Valerie J Block, Gregory M. Marcus, Mark J. Pletcher, Jeffrey E. Olgin, and Bruce A.C. Cree

Subjects
Male, Walking, Relapsing-Remitting, Neurodegenerative, Disability assessment, Disability Evaluation, 0302 clinical medicine, Accelerometry, Medicine, Prospective Studies, 030212 general & internal medicine, Continuous monitoring, Middle Aged, Multiple Sclerosis, Chronic Progressive, Telemedicine, Biomechanical Phenomena, Chronic Progressive, Relapsing, Neurology, Walk test, Neurological, Ambulatory, Female, medicine.medical_specialty, Multiple Sclerosis, Monitoring, Clinical Sciences, Monitoring, Ambulatory, Outcome measurement, Remote physical activity monitoring, Article, 03 medical and health sciences, Multiple Sclerosis, Relapsing-Remitting, Physical medicine and rehabilitation, Progressive, Clinical Research, Humans, Step count, Neurology & Neurosurgery, Expanded Disability Status Scale, business.industry, Multiple sclerosis, Walking (activity), Neurosciences, Reproducibility of Results, medicine.disease, Brain Disorders, Accelerometer, Physical therapy, Neurology (clinical), business, 030217 neurology & neurosurgery
Abstract

Disability measures in multiple sclerosis (MS) rely heavily on ambulatory function, and current metrics fail to capture potentially important variability in walking behavior. We sought to determine whether remote step count monitoring using a consumer-friendly accelerometer (Fitbit Flex) can enhance MS disability assessment. 99 adults with relapsing or progressive MS able to walk ≥2-min were prospectively recruited. At 4weeks, study retention was 97% and median Fitbit use was 97% of days. Substudy validation resulted in high interclass correlations between Fitbit, ActiGraph and manual step count tally during a 2-minute walk test, and between Fitbit and ActiGraph (ICC=0.76) during 7-day home monitoring. Over 4 weeks of continuous monitoring, daily steps were lower in progressive versus relapsing MS (mean difference 2546 steps, p&nbsp

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results